News & Perspective

Feb 08, 2019

Feb 08, 2019

ASP Scan (Weekly) for Feb 08, 2019

Inadequate TB drug-susceptibility testing
New UK guidance on antibiotics for acute cough
FDA to review new Merck antibiotics
CARB-X novel antibiotic funding
Antibiotic prescribing intervention in China
Candida auris fungemia
Microbiology test use in Norway
CRP-guided therapy
Formulary restriction policy
New CARB-X funding

Aug 14, 2019

Aug 14, 2019
Peru TB detection

FDA approves new drug for highly resistant tuberculosis

The shorter, simpler regimen with the new drug is poised to improve treatment against a difficult disease and to lower costs.

Feb 24, 2017

Feb 24, 2017

ASP Scan (Weekly) for Feb 24, 2017

New diagnostic tests
Antibiotic prescribing frequency
Possible Candida auris drug
MRSA pattern shifts
Resistant malaria in Africa
Antibacterial skin lotion
MDR Enterobacteriaceae in children
MCR-1 in Chinese pets
MDR-TB testing, treatment
Neonatal sepsis risk calculator
Antibiotic-free chicken
Klebsiella pneumoniae in UK, Ireland
Antibiotic resistance in Indian kids

May 26, 2016

May 26, 2016

News Scan for May 26, 2016

Last FMSA rule final
H7N9 case in China
Strep in pregnant women
Pseudomonas phage therapy

Apr 04, 2012

Apr 04, 2012

IOM: FDA should work for better product-safety systems abroad

(CIDRAP News) – With the United States importing a vast river of foods and medicines from abroad, the US Food and Drug Administration (FDA) and other organizations need to increase their efforts to improve product safety monitoring in developing countries, the Institute of Medicine (IOM) said in a report released today.

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»